| Cash flow (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | 818.10M | 821.50M | 794.80M | 704.40M | 658.40M | 698.40M | 685.70M | 565.10M |
| Stock-based compensation | 212.80M | 209.50M | 203.30M | 206.00M | 199.90M | 185.20M | 177.00M | 175.80M |
| Cash from operations | 1.06B | 911.90M | 892.50M | 841.00M | 715.40M | 581.60M | 822.60M | 706.50M |
| Capital expenditure | -112.60M | -103.30M | -162.50M | -105.40M | -155.30M | -116.60M | -312.00M | -247.90M |
| Free cash flow | 948.40M | 808.60M | 730.00M | 735.60M | 560.10M | 465.00M | 510.60M | 458.60M |
| Acquisitions | 0 | -528.20M | -12.70M | 0 | -1.20M | 0 | -1.00M | 0 |
| Cash from investing | -26.60M | -914.50M | -209.40M | 401.00M | 260.70M | 213.50M | -1.26B | -1.41B |
| Dividends paid | 0 | 0 | ||||||
| Share buybacks | -320.30M | -1.12B | -201.00M | -1.91B | -181.00M | 0 | 0 | 0 |
| Cash from financing | -287.90M | -1.35B | -137.50M | -1.84B | -147.80M | -235.80M | 49.40M | 98.20M |
| Net change in cash | 753.60M | -1.36B | 557.90M | -597.00M | 829.30M | 554.80M | -383.90M | -620.50M |
From Intuitive Surgical's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.